{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:07:28Z","timestamp":1785150448559,"version":"3.55.0"},"reference-count":23,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,10,15]]},"DOI":"10.2169\/internalmedicine.7391-21","type":"journal-article","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T22:11:07Z","timestamp":1620339067000},"page":"3309-3315","source":"Crossref","is-referenced-by-count":5,"title":["Primary Skeletal Muscle Peripheral T-cell Lymphoma: An Autopsy Case Report and Review of the Literature"],"prefix":"10.2169","volume":"60","author":[{"given":"Hiroko","family":"Iizuka","sequence":"first","affiliation":[{"name":"Department of Hematology, Juntendo University Shizuoka Hospital, Japan"},{"name":"Department of Hematology, Juntendo University Urayasu Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakiko","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University Shizuoka Hospital, Japan"},{"name":"Department of Hematology, Juntendo University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Iwao","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University Shizuoka Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiaki","family":"Koike","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University Shizuoka Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University Urayasu Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Travis WD, Banks PM, Reiman HM. Primary extranodal soft tissue lymphoma of the extremities. Am J Surg Pathol 11: 359-66, 1987.","DOI":"10.1097\/00000478-198705000-00004"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Fragou M, Karakitsos D, Kalogeromitros A, Samonis G, Karabinis A. Peripheral T-cell lymphoma presenting as an ischemic stroke in a 23-year-old woman: a case report and review of the literature. J Med Case Rep 3: 83, 2009.","DOI":"10.1186\/1752-1947-3-83"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Alekshun TJ, Rezania D, Ayala E, Cualing H, Sokol L. Skeletal muscle peripheral T-cell lymphoma. J Clin Oncol 26: 501-503, 2008.","DOI":"10.1200\/JCO.2007.14.2794"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Chim CS, Loong F, Ooi GC, Srivastava G, Liang R. Primary skeletal muscle lymphoma. Am J Med 112: 79-80, 2002.","DOI":"10.1016\/S0002-9343(01)00916-0"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Liu Z, Medeiros LJ, Young KH. Peripheral T-cell lymphoma with unusual clinical presentation of rhabdomyolysis. Hematol Oncol 35: 125-129, 2017.","DOI":"10.1002\/hon.2203"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tanaka Y, Hayashi Y, Kato J, et al. Diffuse skeletal muscles uptake of [<sup>18<\/sup>F] fluorodeoxyglucose on positron emission tomography in primary muscle peripheral T-cell lymphoma. Intern Med 50: 2021-2024, 2011.","DOI":"10.2169\/internalmedicine.50.4992"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Sasaki K, Yamato M, Yasuda K, Rakugi H, Isaka Y. Rhabdomyolysis caused by peripheral T-cell lymphoma in skeletal muscle. Am J Emerg Med 31: 1537.e3-5, 2013.","DOI":"10.1016\/j.ajem.2013.05.034"},{"key":"8","unstructured":"8. Yamaguchi H, Hashimoto M, Mizuki T, et al. Skeletal muscle T-cell lymphoma following hemophagocytic syndrome. Rinsho Ketsueki (Jpn J Clin Hematol) 41: 712-717, 2000 (in Japanese, Abstract in English)."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Yang J, Zhang F, Fang H, Ye Z, Lin S, Han A. Clinicopathologic features of primary lymphoma in soft tissue. Leuk Lymphoma 51: 2039-2046, 2010.","DOI":"10.3109\/10428194.2010.520049"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Savage KJ, Chhanabhai M, Gascoyne RD, Connors JM. Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. Ann Oncol 15: 1467-1475, 2004.","DOI":"10.1093\/annonc\/mdh392"},{"key":"11","unstructured":"11. World Health Organization Classification of Hematopoietic and Lymphoid tissue. Revised 4th ed. Swerdlow SH, Campo E, Pileri SA, et al., Eds. International Agency for Research on Cancer, Lyon, 2017: 453-464."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Keung YK, Liang R. Report of a case of primary skeletal muscle lymphoma and review of the literature. Acta Haematol 96: 184-186, 1996.","DOI":"10.1159\/000203783"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Surov A. Imaging findings of skeletal muscle lymphoma. Clin Imaging 38: 594-598, 2014.","DOI":"10.1016\/j.clinimag.2014.03.006"},{"key":"14","unstructured":"14. Ueno A, Kuribayashi K, Iyama S, et al. Two cases of primary skeletal muscle lymphoma, and a review of the literature. Rinsho Ketsueki (Jpn J Clin Hematol) 46: 1141-1145, 2005 (in Japanese, Abstract in English)."},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Gallamini A, Stelitano C, Calvi R, et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood 103: 2474-2479, 2004.","DOI":"10.1182\/blood-2003-09-3080"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Derenzini E, Casadei B, Pellegrini C, et al. Non-hodgkin lymphomas presenting as soft tissue masses: a single center experience and meta-analysis of the published series. Clin Lymphoma Myeloma Leuk 13: 258-265, 2013.","DOI":"10.1016\/j.clml.2012.10.003"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Vettori S, Staibano S, Mascolo M, et al. Non-Hodgkin&apos;s lymphoma in systemic sclerosis: case and literature review. Clin Rheumatol 29: 1-6, 2010.","DOI":"10.1007\/s10067-009-1286-9"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ichikawa A, Arakawa F, Kiyasu J, et al. Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol 91: 20-28, 2013.","DOI":"10.1111\/ejh.12116"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Zijlmans JM, van Rijthoven AW, Kluin PM, Jiwa NM, Dijkmans BA, Kluin-Nelemans JC. Epstein-Barr virus-associated lymphoma in a patient with rheumatoid arthritis treated with cyclosporine. N Engl J Med 326: 1363, 1992.","DOI":"10.1056\/NEJM199205143262014"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Satou A, Tsuzuki T, Nakamura S. Other Iatrogenic immunodeficiency-associated lymphoproliferative disorders with a T- or NK-cell phenotype. J Clin Exp Hematop 59: 56-63, 2019.","DOI":"10.3960\/jslrt.19013"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Huang HS, Liao CK, Liu TT, You HL, Wang MC, Huang WT. TP53 mutations in peripheral mature T and NK cell lymphomas: a whole-exome sequencing study with correlation to p53 expression. Hum Pathol 80: 145-151, 2018.","DOI":"10.1016\/j.humpath.2018.05.026"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Iqbal J, Wright G, Wang C, et al. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. Blood 123: 2915-2923, 2014.","DOI":"10.1182\/blood-2013-11-536359"},{"key":"23","unstructured":"23. Heavican TB, Bouska A, Yu J, et al. Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma. Blood 133: 1664-1676, 2019."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/20\/60_7391-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T04:41:28Z","timestamp":1715143288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/20\/60_7391-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":23,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7391-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]},"article-number":"7391-21"}}